CFDA: Yet another story? [RSABE / ABEL]

posted by libaiyi – China, 2018-06-12 11:09 (899 d 05:07 ago) – Posting: # 18887
Views: 4,186

Hi Helmut,

thanks for your help.

CFDA has relased the draft guidance for HVBE, which follows FDA method (RSABE).

I still have a question about EMA method. Do you mean if we follow EMA's guidance, the ABEL should be used rather than RSABE, please give me more advise.

thanks in advance. :-D:-D:-D

Complete thread:

Activity
 Admin contact
21,214 posts in 4,427 threads, 1,481 registered users;
online 16 (0 registered, 16 guests [including 13 identified bots]).
Forum time: Friday 15:17 CET (Europe/Vienna)

Biostatistician. One who has neither the intellect for mathematics
nor the commitment for medicine but likes to dabble in both.    Stephen Senn

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5